Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -50.02%10.13M | -7.98%79.29M | 77.58%27.35M | -21.72%17.33M | -37.22%14.35M | -21.39%20.27M | 18.66%86.17M | -29.56%15.4M | 34.47%22.13M | -15.38%22.85M |
Net income from continuing operations | 94.26%6.81M | -85.26%7.2M | -65.73%4.3M | -185.34%-10.88M | -3.07%10.28M | -73.00%3.5M | -18.92%48.87M | -6.62%12.54M | -6.76%12.75M | -33.01%10.61M |
Operating gains losses | 701.49%403K | 203.08%201K | 55.56%-52K | 972.73%192K | 254.22%128K | -348.15%-67K | 70.76%-195K | -550.00%-117K | -340.00%-22K | 62.44%-83K |
Depreciation and amortization | 16.45%9.9M | 69.37%38.59M | 67.17%9.83M | 81.78%10.2M | 77.33%10.07M | 51.25%8.5M | 7.40%22.79M | 4.74%5.88M | 8.72%5.61M | 8.32%5.68M |
Deferred tax | ---- | -682.10%-6.05M | ---- | ---- | ---- | ---- | -49.86%1.04M | ---- | ---- | ---- |
Other non cash items | -106.56%-219K | 383.45%6.08M | 82.90%-248K | 1,474.58%929K | -39.48%2.06M | 545.93%3.34M | -35.90%1.26M | -211.03%-1.45M | 120.70%59K | 1,039.93%3.4M |
Change In working capital | -282.02%-7.85M | 66.90%9.59M | 556.27%18.64M | -274.08%-5.32M | -1,147.92%-8.05M | -28.20%4.32M | 129.23%5.75M | -43.17%-4.09M | 190.17%3.06M | -79.38%768K |
-Change in receivables | -358.12%-20.56M | 909.86%26.82M | 200.61%11.18M | 658.11%7.43M | -97.92%248K | 150.36%7.96M | 111.24%2.66M | -127.90%-11.11M | -154.39%-1.33M | 11.42%11.92M |
-Change in inventory | -3,739.25%-6.77M | 136.77%6.23M | 37.52%7.61M | -68.55%574K | -152.99%-2.15M | 102.12%186K | -66.94%2.63M | -63.03%5.54M | 651.03%1.83M | 416.50%4.05M |
-Change in prepaid assets | -41.81%515K | -447.68%-525K | -48.14%1.14M | 67.61%2.98M | -9.51%-5.53M | -27.46%885K | 110.72%151K | -37.08%2.2M | 124.68%1.78M | 20.08%-5.05M |
-Change in payables and accrued expense | 501.63%18.96M | -7,497.42%-22.93M | -79.64%-1.29M | -2,171.28%-16.3M | 93.86%-623K | -145.44%-4.72M | 111.99%310K | 95.64%-717K | 111.46%787K | -1,720.93%-10.15M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -50.02%10.13M | -7.98%79.29M | 77.58%27.35M | -21.72%17.33M | -37.22%14.35M | -21.39%20.27M | 18.66%86.17M | -29.56%15.4M | 34.47%22.13M | -15.38%22.85M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 97.74%-8.01M | -1,536.88%-372.51M | -103.16%-7M | -75.42%-7.15M | 36.34%-3.83M | -3,745.98%-354.52M | 54.83%-22.76M | 65.66%-3.45M | 38.67%-4.08M | 79.75%-6.02M |
Capital expenditure reported | -41.63%-8.08M | -6.91%-24.44M | -100.20%-7.13M | -76.10%-7.18M | 27.89%-4.42M | 37.22%-5.71M | 5.92%-22.86M | 46.64%-3.56M | 38.91%-4.08M | -4.11%-6.13M |
Net PPE purchase and sale | 1.33%76K | -6.20%242K | 12.07%130K | --28K | -91.74%9K | 127.27%75K | -83.21%258K | 866.67%116K | --0 | -74.23%109K |
Net business purchase and sale | --0 | -217,595.00%-348.31M | --0 | --0 | --578K | -217,956.25%-348.89M | 99.42%-160K | --0 | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 97.74%-8.01M | -1,536.88%-372.51M | -103.16%-7M | -75.42%-7.15M | 36.34%-3.83M | -3,745.98%-354.52M | 54.83%-22.76M | 65.66%-3.45M | 38.67%-4.08M | 79.75%-6.02M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.71%988K | 622.14%295.1M | -165.95%-17.93M | 24.52%-17.93M | 59.30%-5.92M | 3,037.00%336.87M | -246.36%-56.52M | 24.79%-6.74M | -103.70%-23.76M | -287.86%-14.55M |
Net issuance payments of debt | -97.76%7.85M | 985.03%323.41M | -514.82%-13.15M | 31.31%-13.15M | 88.43%-1.15M | 6,683.92%350.86M | -1,561.68%-36.54M | 48.16%-2.14M | -212.57%-19.15M | -187.29%-9.93M |
Net common stock issuance | -129.61%-713K | 42.94%3.34M | -25.90%289K | -22.16%295K | -19.91%350K | 112.72%2.41M | 0.78%2.34M | 49.43%390K | 71.49%379K | -68.03%437K |
Cash dividends paid | 0.52%-5.32M | -0.95%-20.43M | -1.33%-5.04M | -1.11%-5.03M | 0.00%-5.02M | -1.35%-5.35M | -2.24%-20.24M | -0.99%-4.97M | -0.65%-4.97M | -0.54%-5.02M |
Net other financing activities | 92.50%-828K | -441.60%-11.22M | -35.29%-23K | -140.91%-53K | -194.12%-100K | -452.58%-11.05M | -54.63%-2.07M | 90.12%-17K | 97.32%-22K | -1,033.33%-34K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.71%988K | 622.14%295.1M | -165.95%-17.93M | 24.52%-17.93M | 59.30%-5.92M | 3,037.00%336.87M | -246.36%-56.52M | 24.79%-6.74M | -103.70%-23.76M | -287.86%-14.55M |
Net cash flow | ||||||||||
Beginning cash position | 6.38%32.22M | 30.90%30.29M | 19.95%29.71M | 21.68%37.35M | 15.90%32.73M | 30.90%30.29M | 31.06%23.14M | 21.27%24.77M | 36.81%30.69M | 60.68%28.24M |
Current changes in cash | 18.69%3.11M | -72.72%1.88M | -53.58%2.42M | -36.07%-7.76M | 100.87%4.6M | -48.57%2.62M | 16.48%6.9M | 82.15%5.21M | -208.27%-5.7M | -54.59%2.29M |
Effect of exchange rate changes | 82.42%-32K | -80.16%50K | -70.23%92K | 154.02%121K | -88.34%19K | -4,650.00%-182K | 157.40%252K | 310.20%309K | -39.13%-224K | 190.56%163K |
End cash Position | 7.86%35.3M | 6.38%32.22M | 6.38%32.22M | 19.95%29.71M | 21.68%37.35M | 15.90%32.73M | 30.90%30.29M | 30.90%30.29M | 21.27%24.77M | 36.81%30.69M |
Free cash flow | -85.94%2.05M | -13.36%54.86M | 70.78%20.22M | -43.80%10.15M | -40.63%9.93M | -12.77%14.56M | 31.01%63.32M | -22.05%11.84M | 84.49%18.06M | -20.82%16.73M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |